Call Options

2 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2019

Nov 14, 2019

SELL
$42.77 - $50.71 $3.85 Million - $4.56 Million
-90,000 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$44.62 - $49.34 $4.02 Million - $4.44 Million
90,000 New
90,000 $4.08 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Kamunting Street Capital Management, L.P. Portfolio

Follow Kamunting Street Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kamunting Street Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Kamunting Street Capital Management, L.P. with notifications on news.